Clinical Trial

Effect of Itopride on Semaglutide Gastroparesis

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 28, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
Semaglutide delays gastric emptying and increases the risk of aspiration with anesthesia; So, the addition of prokinetics as Itopride, could enhance gastric emptying and hasten surgery. The investigator will evaluate the effect of Itopride on Semaglutide-induced gastroparesis and residual gastric contents after 8 hours of fasting by gastric ultrasound before anesthesia.
Trial Details
NCT Number NCT07254715
Lead Sponsor Ain Shams University
Conditions Semaglutide-Induced Gastric Motility, Anesthesia
Enrollment 60 participants
Start Date 2025-12
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-11-28